Chicago Equity Partners’s ResMed RMD Stock Holding History

Chicago Equity Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$271K	Sell	1,840 -40	-2%	-$6.37K	0.03%	553
2019 Q4	$291K	Sell	1,880 -5,045	-73%	-$727K	0.02%	754
2019 Q3	$936K	Sell	6,925 -7,665	-53%	-$1M	0.04%	516
2019 Q2	$1.78M	Sell	14,590 -6,195	-30%	-$686K	0.08%	357
2019 Q1	$2.16M	Sell	20,785 -38,145	-65%	-$3.94M	0.08%	327
2018 Q4	$6.71M	Buy	58,930 +49,170	+504%	+$5.27M	0.27%	99
2018 Q3	$1.13M	Buy	9,760 +6,355	+187%	+$696K	0.03%	508
2018 Q2	$353K	Buy	+3,405	New	+$345K	0.01%	713
2017 Q2	–	Sell	-23,120	Closed	-$1.66M	–	841
2017 Q1	$1.66M	Buy	+23,120	New	+$1.6M	0.05%	364
2016 Q2	–	Sell	-24,670	Closed	-$1.43M	–	682
2016 Q1	$1.43M	Buy	+24,670	New	+$1.4M	0.04%	303
2014 Q1	–	Sell	-115,120	Closed	-$5.42M	–	481
2013 Q4	$5.42M	Sell	115,120 -72,950	-39%	-$3.69M	0.16%	141
2013 Q3	$9.93M	Sell	188,070 -31,745	-14%	-$1.54M	0.31%	98
2013 Q2	$9.92M	Buy	+219,815	New	+$10.4M	0.31%	97

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Equity Partners's RMD Position: Q1 2020 in Review

Chicago Equity Partners reduced its ResMed (RMD) stake by 2.1% in Q1 2020, selling an estimated $6.37K and leaving 1,840 shares worth $271K. The position accounts for 0.03% of the portfolio, ranked #553.

Chicago Equity Partners first reported a position in RMD in Q2 2013 and has held it in 13 quarters since. The position peaked at $9.93M in Q3 2013. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

Chicago Equity Partners held 1,840 shares of ResMed worth $271K as of Q1 2020.
Chicago Equity Partners sold 40 ResMed shares in Q1 2020, an estimated $6.37K.
ResMed made up 0.03% of Chicago Equity Partners's portfolio in Q1 2020, its #553 holding.
Chicago Equity Partners first reported a position in ResMed in Q2 2013 and has held it in 13 quarters since.
Chicago Equity Partners's ResMed position peaked at $9.93M in Q3 2013.
584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.